B Cell Targeted Treatment In Myasthenia Gravis: A Phase II Trial Of Rituximab In Myasthenia Gravis (Beatmg)
Posted Date: May 15, 2019
- Investigator: Laura Ann Sams
- Type of Study: Drug
The purpose of this study is to find out if rituximab is effective and safe in people with myasthenia gravis (MG) who are also taking prednisone. The study will determine if rituximab will help people take less prednisone to manage their myasthenia gravis or possibly be able to stop taking prednison
Criteria:
You Are Being Asked To Take Part In This Research Study Because You Have Myasthenia Gravis And Take
Keywords:
Prednisone, Neuromuscular, Myasthenia Gravis, Rituximab
For More Information:
Linda Lovell-Ewen
513-558-5023
linda.lovell-ewen@uc.edu